BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 25188274)

  • 1. Genetic polymorphisms and kidney transplant outcomes.
    Chand S; McKnight AJ; Borrows R
    Curr Opin Nephrol Hypertens; 2014 Nov; 23(6):605-10. PubMed ID: 25188274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic prediction of renal transplant outcome.
    Goldfarb-Rumyantzev AS; Naiman N
    Curr Opin Nephrol Hypertens; 2008 Nov; 17(6):573-9. PubMed ID: 18941349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The functional polymorphism Ala258Ser in the innate receptor gene ficolin-2 in the donor predicts improved renal transplant outcome.
    Eikmans M; de Canck I; van der Pol P; Baan CC; Haasnoot GW; Mallat MJ; Vergunst M; de Meester E; Roodnat JI; Anholts JD; van Thielen M; Doxiadis II; de Fijter JW; van der Linden PJ; van Beelen E; van Kooten C; Kal-van Gestel JA; Peeters AM; Weimar W; Roelen DL; Rossau R; Claas FH
    Transplantation; 2012 Sep; 94(5):478-85. PubMed ID: 22892990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms and the fate of the transplanted organ.
    Krüger B; Schröppel B; Murphy BT
    Transplant Rev (Orlando); 2008 Apr; 22(2):131-40. PubMed ID: 18631866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic association of FOXP3 gene polymorphisms with allograft rejection in renal transplant patients.
    Qiu XY; Jiao Z; Zhang M; Chen JP; Shi XJ; Zhong MK
    Nephrology (Carlton); 2012 May; 17(4):423-30. PubMed ID: 22239151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor 4 and CD14 gene polymorphisms in Tunisian kidney transplantation.
    Krichen H; Gorgi Y; Dhaouadi T; Mecheri Y; Sfar I; Bardi R; Bacha MM; Abderrahim E; Jendoubi-Ayed S; Ayed K; Ben Abdallah T
    Transplant Proc; 2013; 45(10):3472-7. PubMed ID: 24314935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genes and beans: pharmacogenomics of renal transplant.
    Murray B; Hawes E; Lee RA; Watson R; Roederer MW
    Pharmacogenomics; 2013 May; 14(7):783-98. PubMed ID: 23651025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human leukocyte antigen-G-14-base-pair-insertion/deletion polymorphism and graft survival in kidney transplant recipients.
    Hou W; Huang Z; Ji Z; Zhou J
    Exp Clin Transplant; 2014 Apr; 12(2):89-94. PubMed ID: 24702138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetic vs. concentration-controlled optimization of tacrolimus dosing in renal allograft recipients.
    Kuypers DR
    Clin Pharmacol Ther; 2010 Nov; 88(5):595-6; author reply 597. PubMed ID: 20664539
    [No Abstract]   [Full Text] [Related]  

  • 10. Rationale and criteria of eligibility for calcineurin inhibitor interruption following kidney transplantation.
    Danger R; Giral M; Soulillou JP; Brouard S
    Curr Opin Organ Transplant; 2008 Dec; 13(6):609-13. PubMed ID: 19060551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine gene polymorphisms in kidney transplantation.
    Dhaouadi T; Sfar I; Bardi R; Jendoubi-Ayed S; Abdallah TB; Ayed K; Gorgi Y
    Transplant Proc; 2013; 45(6):2152-7. PubMed ID: 23747182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practicability of pharmacogenetics in transplantation medicine.
    van Gelder T; van Schaik RH; Hesselink DA
    Clin Pharmacol Ther; 2014 Mar; 95(3):262-4. PubMed ID: 23995265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic determinants of renal transplant outcome: where do we stand?
    Phelan PJ; Conlon PJ; Sparks MA
    J Nephrol; 2014 Jun; 27(3):247-56. PubMed ID: 24515316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of glutathion S-transferase polymoprhisms and anti-GSTT1 antibodies on allograft functions in recipients of renal transplant.
    Akgul SU; Oguz FS; Çalişkan Y; Kekik C; Gürkan H; Türkmen A; Nane I; Aydin F
    Transplant Proc; 2012; 44(6):1679-84. PubMed ID: 22841242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of donor-dependent genetic factors on long-term renal graft function.
    Krajewska M; Kościelska-Kasprzak K; Weyde W; Drulis-Fajdasz D; Madziarska K; Mazanowska O; Kusztal M; Klinger M
    Transplant Proc; 2009 Oct; 41(8):2978-80. PubMed ID: 19857655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor 3 L412F polymorphism may protect against acute graft rejection in adult patients undergoing liver transplantation for hepatitis C-related cirrhosis.
    Citores MJ; Baños I; Noblejas A; Rosado S; Castejon R; Cuervas-Mons V
    Transplant Proc; 2011; 43(6):2224-6. PubMed ID: 21839239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic interactions between the donor and the recipient for susceptibility to acute rejection in kidney transplantation: polymorphisms of CCR5.
    Cha RH; Yang SH; Kim HS; Kim SM; Park MH; Ha J; Kim YS
    Nephrol Dial Transplant; 2009 Sep; 24(9):2919-25. PubMed ID: 19561149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association studies of Toll-like receptor gene polymorphisms with allograft survival in renal transplant recipients of North India.
    Srivastava P; Singh A; Kesarwani P; Jaiswal PK; Singh V; Mittal RD
    Clin Transplant; 2012; 26(4):581-8. PubMed ID: 22251233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune monitoring in small bowel transplantation.
    Sindhi R; AshokKumar C; Mazariegos G; Nayyar N; Ningappa M; Soltys K; Bond G; Sun Q; Humar A; Abu-Elmagd K; Zeevi A
    Curr Opin Organ Transplant; 2010 Jun; 15(3):349-56. PubMed ID: 20489630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppression in high-risk transplantation.
    Rhee J; Al-Mana N; Freeman R
    Curr Opin Organ Transplant; 2009 Dec; 14(6):636-42. PubMed ID: 19812495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.